David Zeferino D'Azevedo Cristina
Vorstandsvorsitzender bei Acellera Therapeutics Lda.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Diogo Remechido | M | - |
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
| Rafael Conceição | M | - |
Portugal Capital Ventures SCR SA
 Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 8 Jahre |
| Martinho Tojo | M | - |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
| Luis Ricardo Simões da Silva Graca | M | - |
Acellera Therapeutics Lda.
 Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | 14 Jahre |
| Marta Sofia Ferreira Monteiro Coelho | M | - |
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | 14 Jahre |
| Daniel Correia | M | - |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
| Bruno Silva-Santos | M | - |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
| João Sampayo Ramos | M | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 9 Jahre |
| Pedro Cunha | M | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 8 Jahre |
| Julie Dechanet-Merville | F | - |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
| Domenico Mavilio | M | - |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Miguel Maya Dias Pinheiro | M | 60 |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 3 Jahre |
| Joana Bicudo | F | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 4 Jahre |
| Diogo André Pedroso Patão | M | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 4 Jahre |
| Caspar Guggenbuehl | M | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 2 Jahre |
| Nuno Miguel Duarte Afonso | M | - |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Portugal | 16 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Zeferino D'Azevedo Cristina
- Persönliches Netzwerk
